Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302). (Record no. 9294136)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01386 a2200373 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513125611.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199710s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0022-3565 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Glover, J M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19971017 |
245 00 - TITLE STATEMENT | |
Title | Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302). |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The Journal of pharmacology and experimental therapeutics |
Date of publication, distribution, etc. | Sep 1997 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1173-80 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Intercellular Adhesion Molecule-1 |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oligodeoxyribonucleotides, Antisense |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oligonucleotides, Antisense |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphorothioate Oligonucleotides |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Thionucleotides |
General subdivision | adverse effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Leeds, J M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mant, T G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Amin, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kisner, D L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zuckerman, J E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Geary, R S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Levin, A A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shanahan, W R |
773 0# - HOST ITEM ENTRY | |
Title | The Journal of pharmacology and experimental therapeutics |
Related parts | vol. 282 |
-- | no. 3 |
-- | p. 1173-80 |
No items available.